Thorac Cardiovasc Surg
DOI: 10.1055/a-2652-7957
Original Thoracic

Lung Chemoperfusion Improves Relapse-Free Survival after Metastasectomy for Colorectal Cancer

1   Department of Thoracic Oncology, N.N. Petrov National Medical Research Center of Oncology, Pesochny, Saint Petersburg, Russia
2   Department of Oncology, I.I. Mechnikov North-Western State Medical University, Saint Petersburg, Russia
,
3   Department of Thoracic Oncology, State Budgetary Healthcare Institution of Stavropol Region (Stavropol regional Clinical Oncological dispensary), Stavropol, Russia
,
1   Department of Thoracic Oncology, N.N. Petrov National Medical Research Center of Oncology, Pesochny, Saint Petersburg, Russia
,
1   Department of Thoracic Oncology, N.N. Petrov National Medical Research Center of Oncology, Pesochny, Saint Petersburg, Russia
,
1   Department of Thoracic Oncology, N.N. Petrov National Medical Research Center of Oncology, Pesochny, Saint Petersburg, Russia
4   Department of Oncology, I.P. Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia
,
1   Department of Thoracic Oncology, N.N. Petrov National Medical Research Center of Oncology, Pesochny, Saint Petersburg, Russia
,
1   Department of Thoracic Oncology, N.N. Petrov National Medical Research Center of Oncology, Pesochny, Saint Petersburg, Russia
› Author Affiliations
Preview

Abstract

Introduction

Metastasectomy is a recommended and widely used operation for pulmonary metastases from colorectal cancer (CRC). The main disadvantage of pulmonary metastasectomy is the high rate of metastasis recurrence, which occurs in almost half of patients. To suppress residual pulmonary microfoci, isolated lung chemoperfusion (ILuP) is used, but its effectiveness has not been studied.

Material and Methods

The results of pulmonary metastasectomy were studied in 160 patients. In 65 patients of the main group, open metastasectomy with isolated chemoperfusion of the lungs was performed; in 95 patients of the control group, standard open or thoracoscopic metastasectomy was performed. The study design included 1:1 pseudorandomization using the nearest neighbor method. For 17 patients who underwent standard metastasectomy and then metastasectomy with ILuP for recurrent pulmonary metastases, these patients themselves were used as the nearest neighbor. For the remaining patients, the matching pairs were selected by the Propensity Score Matching method. After balancing the sample, the main and control groups comprised 41 pairs of observations, which were subjected to further analysis with assessment of relapse-free pulmonary survival according to Kaplan–Meier. Factors influencing survival were studied in the Cox's model.

Results

The median recurrence-free survival in patients of the main group who underwent metastasectomy with ILuP was 22.3 months versus 9.1 months in the control group. One-year recurrence-free survival in the main group was 77.5 ±  6.6% versus 38.1 ± 9.1% in the control group.

Conclusion

Isolated lung chemoperfusion increases median recurrence-free survival after pulmonary metastasectomy by more than one year for colorectal cancer.



Publication History

Received: 24 March 2025

Accepted: 08 July 2025

Accepted Manuscript online:
11 July 2025

Article published online:
24 July 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany